Naltrexone for probationers and parolees
- PMID: 16919734
- DOI: 10.1016/j.jsat.2006.06.002
Naltrexone for probationers and parolees
Abstract
Heroin addiction is a chronic disorder that is usually associated with crimes aimed to obtain funds for the purchase of this illegal drug. When these addicted individuals are apprehended and incarcerated, they temporarily obtain drug-free status, but relapse quickly upon release. There is a medication approved by the Food and Drug Administration (naltrexone) that could prevent relapse and thus break this revolving door cycle. In combination with counseling, former inmates could devote energies to legal jobs or job training instead of drug seeking. The major reasons for the nonuse of this medication appear to be lack of knowledge about the medication and fear that the use of a medication that blocks opiate receptors is somehow unethical. This special issue presents data, discussions, and suggestions regarding the ethical use of naltrexone in incarcerated populations or in those under supervision for parole or probation.
Comment in
-
Regarding naltrexone for probationers and parolees.J Subst Abuse Treat. 2007 Mar;32(2):217-8; author reply 218-9. doi: 10.1016/j.jsat.2006.11.011. Epub 2007 Feb 1. J Subst Abuse Treat. 2007. PMID: 17306730 No abstract available.
Similar articles
-
Research on naltrexone in the criminal justice system.J Subst Abuse Treat. 2006 Sep;31(2):113-5. doi: 10.1016/j.jsat.2006.06.021. Epub 2006 Aug 2. J Subst Abuse Treat. 2006. PMID: 16919735 Review.
-
Judicially mandated naltrexone use by criminal offenders: a legal analysis.J Subst Abuse Treat. 2006 Sep;31(2):121-7. doi: 10.1016/j.jsat.2006.06.003. Epub 2006 Aug 2. J Subst Abuse Treat. 2006. PMID: 16919737
-
Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".J Subst Abuse Treat. 2006 Sep;31(2):129-30. doi: 10.1016/j.jsat.2006.06.004. Epub 2006 Aug 2. J Subst Abuse Treat. 2006. PMID: 16919738 No abstract available.
-
Regarding naltrexone for probationers and parolees.J Subst Abuse Treat. 2007 Mar;32(2):217-8; author reply 218-9. doi: 10.1016/j.jsat.2006.11.011. Epub 2007 Feb 1. J Subst Abuse Treat. 2007. PMID: 17306730 No abstract available.
-
A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?Eur Addict Res. 2009;15(2):107-12. doi: 10.1159/000199046. Epub 2009 Feb 2. Eur Addict Res. 2009. PMID: 19182485 Review.
Cited by
-
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers.Subst Abus. 2012;33(1):48-59. doi: 10.1080/08897077.2011.609438. Subst Abus. 2012. PMID: 22263713 Free PMC article.
-
Medication Treatment for Opioid Use Disorders:: A Brief Overview with Comments on Extended Release Naltrexone.Dela J Public Health. 2017 Aug 30;3(4):42-44. doi: 10.32481/djph.2017.08.010. eCollection 2017 Aug. Dela J Public Health. 2017. PMID: 34466930 Free PMC article. No abstract available.
-
Daily stressors as antecedents, correlates, and consequences of alcohol and drug use and cravings in community-based offenders.Psychol Addict Behav. 2017 May;31(3):315-325. doi: 10.1037/adb0000276. Epub 2017 Apr 6. Psychol Addict Behav. 2017. PMID: 28383933 Free PMC article.
-
Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.Drug Alcohol Depend. 2011 May 1;115(1-2):23-9. doi: 10.1016/j.drugalcdep.2010.10.016. Epub 2010 Dec 3. Drug Alcohol Depend. 2011. PMID: 21126830 Free PMC article.
-
Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.Subst Abuse Rehabil. 2011 Jun;2011(2):113-123. doi: 10.2147/SAR.S15853. Subst Abuse Rehabil. 2011. PMID: 21731898 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical